口服甘露糖成功治疗1b型碳水化合物缺乏糖蛋白综合征。
Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose.
作者信息
Hendriksz C J, McClean P, Henderson M J, Keir D G, Worthington V C, Imtiaz F, Schollen E, Matthijs G, Winchester B G
机构信息
Children's Liver and GI Unit, Department of Paediatrics, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK.
出版信息
Arch Dis Child. 2001 Oct;85(4):339-40. doi: 10.1136/adc.85.4.339.
Abstract
An Asian girl presented with failure to thrive, congenital hepatic fibrosis, protein losing enteropathy, and hypoglycaemia. Phosphomannose isomerase activity in skin fibroblasts was reduced. She is homozygous for a mutation, D131N, in the phosphomannose isomerase gene (PM1), consistent with the diagnosis of carbohydrate deficient glycoprotein syndrome type 1b. She responded to oral mannose treatment.
摘要
一名亚洲女孩出现生长发育迟缓、先天性肝纤维化、蛋白丢失性肠病和低血糖症状。皮肤成纤维细胞中的磷酸甘露糖异构酶活性降低。她的磷酸甘露糖异构酶基因（PM1）存在D131N突变的纯合子，符合1b型碳水化合物缺乏糖蛋白综合征的诊断。她对口服甘露糖治疗有反应。
相似文献
1
Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose.口服甘露糖成功治疗1b型碳水化合物缺乏糖蛋白综合征。
Arch Dis Child. 2001 Oct;85(4):339-40. doi: 10.1136/adc.85.4.339.
2
[Carbohydrate-deficient glycoprotein syndrome (CDGS) type Ib. A hereditary metabolic disease and its therapy].
MMW Fortschr Med. 2000 Jan 20;142(3 Suppl):171-2.
3
Carbohydrate-deficient glycoprotein syndrome 1b: a new answer to an old diagnostic dilemma.
J Paediatr Child Health. 2001 Oct;37(5):510-2. doi: 10.1046/j.1440-1754.2001.00671.x.
4
Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose.高胰岛素血症性低血糖作为磷酸甘露糖异构酶缺乏症的首发症状：一种可通过甘露糖治疗的糖蛋白缺乏综合征的新表现。
J Pediatr. 1999 Sep;135(3):379-83. doi: 10.1016/s0022-3476(99)70139-3.
5
A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation.磷酸甘露糖异构酶缺乏症所致先天性糖基化障碍的斑马鱼模型揭示了早期进行补救性甘露糖补充的机会。
Dis Model Mech. 2013 Jan;6(1):95-105. doi: 10.1242/dmm.010116. Epub 2012 Aug 16.
6
Seizures and stupor during intravenous mannose therapy in a patient with CDG syndrome type 1b (MPI-CDG).患者在静脉滴注甘露糖治疗 1b 型黏多糖贮积症（MPI-CDG）时出现抽搐和昏迷。
J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S497-502. doi: 10.1007/s10545-010-9252-x. Epub 2011 Jan 16.
7
Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.Ib型糖缺乏糖蛋白综合征。磷酸甘露糖异构酶缺乏与甘露糖治疗。
J Clin Invest. 1998 Apr 1;101(7):1414-20. doi: 10.1172/JCI2350.
8
Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency.口服甘露糖疗法可持久纠正磷酸甘露糖异构酶缺乏症的严重临床症状和生化异常。
Acta Paediatr. 2002;91(10):1065-72. doi: 10.1080/080352502760311566.
9
Protein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation type Ib.魁北克萨格奈-圣让湖区的蛋白丢失性肠病-肝纤维化综合征是一种Ib型先天性糖基化障碍疾病。
J Med Genet. 2002 Nov;39(11):849-51. doi: 10.1136/jmg.39.11.849.
10
Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation.首例成人先天性糖基化代谢异常Ib型的遗传与代谢分析：长期预后及甘露糖补充的影响
Mol Genet Metab. 2001 May;73(1):77-85. doi: 10.1006/mgme.2001.3161.
引用本文的文献
1
Mapping the diagnostic odyssey of congenital disorders of glycosylation (CDG): insights from the community.绘制先天性糖基化障碍（CDG）的诊断之旅：来自社区的见解。
Orphanet J Rare Dis. 2024 Nov 1;19(1):407. doi: 10.1186/s13023-024-03389-2.
2
Liver transplantation recovers hepatic N-glycosylation with persistent IgG glycosylation abnormalities: Three-year follow-up in a patient with phosphomannomutase-2-congenital disorder of glycosylation.肝移植恢复肝 N-糖基化，伴有持续的 IgG 糖基化异常：一例磷酸甘露糖变位酶-2 先天性糖基化障碍患者的 3 年随访。
Mol Genet Metab. 2023 Apr;138(4):107559. doi: 10.1016/j.ymgme.2023.107559. Epub 2023 Mar 17.
3
Identification and characterization of circulating immune complexes in IgA nephropathy.鉴定和描述 IgA 肾病中的循环免疫复合物。
Sci Adv. 2022 Oct 28;8(43):eabm8783. doi: 10.1126/sciadv.abm8783.
4
Treatment Options in Congenital Disorders of Glycosylation.先天性糖基化障碍的治疗选择
Front Genet. 2021 Sep 10;12:735348. doi: 10.3389/fgene.2021.735348. eCollection 2021.
5
Fructose and Mannose in Inborn Errors of Metabolism and Cancer.代谢先天性疾病和癌症中的果糖与甘露糖
Metabolites. 2021 Jul 25;11(8):479. doi: 10.3390/metabo11080479.
6
Liver Involvement in Congenital Disorders of Glycosylation and Deglycosylation.肝脏在先天性糖基化和去糖基化紊乱中的表现
Front Pediatr. 2021 Jul 5;9:696918. doi: 10.3389/fped.2021.696918. eCollection 2021.
7
MPI-CDG from a hepatic perspective: Report of two Egyptian cases and review of literature.从肝脏角度看MPI-CDG：两例埃及病例报告及文献综述。
JIMD Rep. 2020 Sep 7;56(1):20-26. doi: 10.1002/jmd2.12159. eCollection 2020 Nov.
8
Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy.一名停用甘露糖治疗的磷酸甘露糖异构酶先天性糖基化障碍成年患者的临床结局
Mol Genet Metab Rep. 2020 Sep 7;25:100646. doi: 10.1016/j.ymgmr.2020.100646. eCollection 2020 Dec.
9
Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation.甘露糖磷酸异构酶-先天性糖基化障碍的诊断和管理共识指南
J Inherit Metab Dis. 2020 Jul;43(4):671-693. doi: 10.1002/jimd.12241. Epub 2020 Apr 21.
10
Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update.先天性糖基化障碍（CDG）中涉及 N-连接糖基化的治疗方法：最新进展。
Genet Med. 2020 Feb;22(2):268-279. doi: 10.1038/s41436-019-0647-2. Epub 2019 Sep 19.
Zotero 插件